{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:31:03Z","timestamp":1761129063900},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s40261-012-0022-4","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T11:51:45Z","timestamp":1359978705000},"page":"51-55","source":"Crossref","is-referenced-by-count":21,"title":["Invasive Coinfection with Aspergillus and Mucor in a Patient with Acute Myeloid Leukemia"],"prefix":"10.1007","volume":"33","author":[{"given":"Rui","family":"Bergantim","sequence":"first","affiliation":[]},{"given":"Elisabete","family":"Rios","sequence":"additional","affiliation":[]},{"given":"Fernanda","family":"Trigo","sequence":"additional","affiliation":[]},{"given":"Jose Eduardo","family":"Guimar\u00e3es","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,2,5]]},"reference":[{"key":"22_CR1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1086\/649879","volume":"50","author":"K Leventakos","year":"2010","unstructured":"Leventakos K, Lewis RE, Kontoyannis DP. Fungal infections in leukemia patients: how do we prevent and treat them? Clin Infect Dis. 2010;50:405\u201315.","journal-title":"Clin Infect Dis"},{"key":"22_CR2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3324\/haematol.2009.012054","volume":"95","author":"L Pagano","year":"2010","unstructured":"Pagano L, Caira M, Candoni, Offidani M, Martino B, Specchia G, et al. Invasive aspergillosis in patients with acute myeloid leukaemia: a SEIFEM 2008 registry study. Haematologica. 2010;95:644\u201350.","journal-title":"Haematologica"},{"key":"22_CR3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.blre.2009.11.003","volume":"24","author":"L Pagano","year":"2010","unstructured":"Pagano L, Caira M, Gioavana C, Posteraro B, Fianchi L. Current therapeutic approaches to fungal infections in immunocompromised hematological patients. Blood Rev. 2010;24:51\u201361.","journal-title":"Blood Rev"},{"key":"22_CR4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3324\/haematol.2010.030825","volume":"96","author":"C Even","year":"2011","unstructured":"Even C, Bastujin-Garin S, Hicheri Y, Pautas C, Botterel F, Maury S, et al. Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukaemia patients who survived fungal disease: a case control study. Haematologica. 2011;96:337\u201341.","journal-title":"Haematologica"},{"key":"22_CR5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","volume":"46","author":"TJ Walsh","year":"2008","unstructured":"Walsh TJ, Anaissie E, Denning DW, et al. Treatment of Aspergillosis: clinical practice guidelines of the Infectious Diseases Society of Am\u00e9rica. Clin Infect Dis. 2008;46:327\u201360.","journal-title":"Clin Infect Dis"},{"key":"22_CR6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3324\/haematol.11665","volume":"94","author":"OA Cornely","year":"2009","unstructured":"Cornely OA, Bohme A, Buchheidt D, Einsele H, Heinz WJ, Karthaus M, et al. Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendation of the Infectious Diseases Working Group of the German Society for Haematology and Oncology. Haematologica. 2009;94:113\u201321.","journal-title":"Haematologica"},{"key":"22_CR7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2141.2009.07738.x","volume":"146","author":"L Pagano","year":"2009","unstructured":"Pagano L, Valentin CG, Caira M, Fianchi L. Zygomycosis: current approaches to management of patients with haematological malignancies. Brit J Haematol. 2009;146:597\u2013606.","journal-title":"Brit J Haematol"},{"key":"22_CR8","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3324\/haematol.2010.028878","volume":"95","author":"C Girmenia","year":"2010","unstructured":"Girmenia C. Prophylaxis of invasive fungal disease in patients with hematological disorders. Haematologica. 2010;95:1630\u20133.","journal-title":"Haematologica"},{"key":"22_CR9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","volume":"356","author":"OA Cornely","year":"2007","unstructured":"Cornely OA, Maertens J, Winston DJ, et al. Posaconazole vs. Fluconazole or Itraconazole prophylaxis in patients with neutropenia. N Engl J Med. 2007;356:348\u201359.","journal-title":"N Engl J Med"},{"key":"22_CR10","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/597395","volume":"48","author":"C Cordonnier","year":"2009","unstructured":"Cordonnier C, Pautas C, Maury S, et al. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Clin Infect Dis. 2009;48:1042\u201351.","journal-title":"Clin Infect Dis"},{"key":"22_CR11","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B Pauw De","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for research and treatment of C\u00e2ncer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813\u201321.","journal-title":"Clin Infect Dis"},{"key":"22_CR12","doi-asserted-by":"crossref","unstructured":"Maertens J, Marchetti O, Herbrecht R, Cornely OA, Fluckiger U, fr\u00e8re P, et al. European Guidelines for antifungal management in leukaemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3\u20142009 update. Bone Marrow Transpl; 2010 (Epub ahead of print).","DOI":"10.1038\/bmt.2010.175"},{"key":"22_CR13","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","volume":"44","author":"OA Cornely","year":"2007","unstructured":"Cornely OA, Maertens J, Bresnik M, et al. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose reg\u00edmen with standard dosing (AmBiLoad Trial). Clin Infect Dis. 2007;44:1289\u201397.","journal-title":"Clin Infect Dis."},{"key":"22_CR14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1439-0507.2008.01672.x","volume":"53","author":"CG Valentini","year":"2010","unstructured":"Valentini CG, Candoni A, Fianchi L, et al. Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies. Mycoses. 2010;53:89\u201392.","journal-title":"Mycoses"},{"key":"22_CR15","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1086\/503844","volume":"42","author":"N Sipsas","year":"2006","unstructured":"Sipsas N, Kontoyiannis DP. Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies. Clin Infect Dis. 2006;42:1584\u201391.","journal-title":"Clin Infect Dis"},{"key":"22_CR16","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/jac\/dkn027","volume":"61","author":"OA Cornely","year":"2008","unstructured":"Cornely OA, Bohme A, Reichert D, Reuter S, Maschmeyer, Maertens J, et al. Risk factors for breakthrough invasive fungal infection during secondary prophylaxis. J Antimicrob Chemother. 2008;61:939\u201346.","journal-title":"J Antimicrob Chemother"},{"key":"22_CR17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347:408\u201315.","journal-title":"N Engl J Med"},{"key":"22_CR18","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/sj.bmt.1704469","volume":"33","author":"C Cordonnier","year":"2004","unstructured":"Cordonnier C, Maury S, Pautas C, Bastie JN, Chehata S, Kuentz M, et al. Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients. Bone Marrow Transpl. 2004;33:943\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"22_CR19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1439-0507.2001.00644.x","volume":"44","author":"L Mele","year":"2001","unstructured":"Mele L, Pagano L, Equitani F, Leone G. Secondary prophylaxis with liposomal amphotericin B after invasive Aspergillosis following treatment for haematological malignancy. Mycoses. 2001;44:201\u20133.","journal-title":"Mycoses"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-012-0022-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-012-0022-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-012-0022-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T02:37:48Z","timestamp":1562639868000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-012-0022-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":19,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s40261-012-0022-4","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}